Med Check: Olanzapine LAI Provides Long-Term Stability, Lumateperone Scores First Phase 3 Win, Helus Pharma Advances Psychedelic Adjunctive, and More
Year: 2026
Type: other
Source: Psychiatric News
Author: Linda M. Richmond
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7224789117